# SilicoLife Lda.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/silicolife-lda

- Industry: Biotechnology
- Headquarters: Portugal
- Website: www.silicolife.com
- Total disclosed funding: $5.2M
- Latest round: Series A (Dec 7, 2022)
- Investors on record: 1

## About

Founded in 2010 and based in Braga, Portugal, SilicoLife Lda. operates as a biotechnology company that focuses on microorganisms and novel pathways using metabolic engineering and synthetic biology approaches. In December 2022, SilicoLife Lda., raised EUR 4.9 million in series A funding from BlueCrow. As of 2022, the company is led by its CEO, Simão Soares along with 16 employees.

The company offers metabolic engineering and synthetic biology used to produce compounds such as chemicals, food ingredients, or biopolymers. The company designs biosynthetic pathways for both natural and unnatural compounds using engineered enzymes. Its methodology includes system biology, bioinformatics, artificial intelligence, text mining, and metabolic engineering.

The company plans to use its December 2022 funding to accelerate its product development and expand its team.

## Funding rounds

- Series A, Dec 7, 2022, $5.2M — BlueCrow Capital

## Investors

- BlueCrow Capital (https://capitalatlas.ai/funds/bluecrow-capital) — Series A